Medical Assistance Programs - Drug Dispensing - Cost-of-Dispensing Survey
Impact
The enactment of HB 1470 is expected to create a standardized approach to evaluating and compensating pharmacies for dispensing medications to Medicaid recipients. By instituting regular evaluations of dispensing costs, the legislation aims to ensure that fees reflect current economic realities and the operational expenses faced by pharmacies. This may lead to a more sustainable and efficient medical assistance program, potentially improving the accessibility of medications for low-income residents relying on Medicaid services.
Summary
House Bill 1470 introduces provisions to enhance the Medicaid program's drug dispensing practices in Maryland. The bill mandates the Maryland Department of Health to conduct an in-state cost-of-dispensing survey at least once every three years, starting in 2026. This survey aims to assess the expenses associated with dispensing medications under the Medicaid program and requires the department to report its findings to the General Assembly annually. Based on the survey results, the Department is also tasked with establishing a fee-for-service professional dispensing fee within six months of completing the survey.
Sentiment
The sentiment surrounding HB 1470 appears to be largely supportive, reflecting a recognition of the need to adapt and optimize compensation structures for pharmacy services. Stakeholders, including pharmacy representatives and health advocates, have generally portrayed the bill as a necessary reform for ensuring fair reimbursement for dispensing services. There are indications that many believe these changes could enhance pharmacy participation in the Medicaid program, thus improving patient care and access to necessary medications.
Contention
While support for HB 1470 has been voiced among various stakeholders, some concerns linger about the potential administrative burden this may place on the Department of Health. Critics emphasize that conducting the periodic surveys and implementing the associated regulations could require significant resources and oversight, especially in the first few years. Opponents argue that the shifting of medical dispensing fees might lead to unintended consequences affecting smaller or rural pharmacies that already face financial challenges.
Maryland Medical Assistance Program and Health Insurance - Coverage and Utilization Review - Drugs Reviewed by the Prescription Drug Affordability Board